Literature DB >> 10823135

Improved prognosis of Epstein-Barr virus associated childhood Hodgkin's lymphoma: study of 47 South African cases.

M Engel1, M F Essop, P Close, P Hartley, G Pallesen, C Sinclair-Smith.   

Abstract

AIM: To study the distribution of Hodgkin's lymphoma in South African children and report the incidence of Epstein-Barr virus (EBV) as regards age, race, sex, and histological subtype; to investigate whether EBV is relevant to survival.
METHODS: Immunohistochemistry (IHC) and in situ hybridisation (ISH) to detect EBV were performed on 47 South African children with classical Hodgkin's lymphoma, ranging in age from 3 to 14 years and coming from different ethnic backgrounds. The correlation between the presence of the virus and clinical outcome was assessed.
RESULTS: The nodular sclerosing subtype predominated, comprising 89% of cases; the remaining 11% were of the mixed cellularity subtype. EBV was present in 68%. Full clinical data were available for 36 cases; EBV positive patients presented with less aggressive symptoms at diagnosis and had a significantly longer median survival than EBV negative patients.
CONCLUSIONS: The distribution of EBV in South African childhood Hodgkin's lymphoma follows a pattern intermediate to that of industrialised and non-industrialized countries. Furthermore, our data suggest that there is an association between poor prognosis and the non-detection of EBV products in South African childhood Hodgkin's lymphoma.

Entities:  

Mesh:

Year:  2000        PMID: 10823135      PMCID: PMC1731151          DOI: 10.1136/jcp.53.3.182

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  42 in total

1.  Adverse clinical outcome in Hodgkin's disease is associated with loss of retinoblastoma protein expression, high Ki67 proliferation index, and absence of Epstein-Barr virus-latent membrane protein 1 expression.

Authors:  M M Morente; M A Piris; V Abraira; A Acevedo; B Aguilera; C Bellas; M Fraga; R Garcia-Del-Moral; F Gomez-Marcos; J Menarguez; H Oliva; M Sanchez-Beato; C Montalban
Journal:  Blood       Date:  1997-09-15       Impact factor: 22.113

2.  Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients.

Authors:  D Liebowitz
Journal:  N Engl J Med       Date:  1998-05-14       Impact factor: 91.245

3.  Demonstration of Epstein-Barr viral DNA in formalin-fixed, paraffin-embedded samples of Hodgkin's disease.

Authors:  C M Libetta; J H Pringle; C A Angel; A W Craft; A J Malcolm; I Lauder
Journal:  J Pathol       Date:  1990-07       Impact factor: 7.996

4.  Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data.

Authors:  S L Glaser; R J Lin; S L Stewart; R F Ambinder; R F Jarrett; P Brousset; G Pallesen; M L Gulley; G Khan; J O'Grady; M Hummel; M V Preciado; H Knecht; J K Chan; A Claviez
Journal:  Int J Cancer       Date:  1997-02-07       Impact factor: 7.396

5.  Epidemiology of hodgkin's disease in the young.

Authors:  N Gutensohn; P Cole
Journal:  Int J Cancer       Date:  1977-05-15       Impact factor: 7.396

6.  Detection of Epstein-Barr virus genomes in Hodgkin's disease: relation to age.

Authors:  R F Jarrett; A Gallagher; D B Jones; F E Alexander; A S Krajewski; A Kelsey; J Adams; B Angus; S Gledhill; D H Wright
Journal:  J Clin Pathol       Date:  1991-10       Impact factor: 3.411

Review 7.  Epstein-Barr virus in Hodgkin's disease: more than just an innocent bystander.

Authors:  J J Oudejans; N M Jiwa; C J Meijer
Journal:  J Pathol       Date:  1997-04       Impact factor: 7.996

8.  Longitudinal study of Epstein-Barr virus antibody titers and excretion in pediatric patients with Hodgkin's disease.

Authors:  B Lange; A Arbeter; J Hewetson; W Henle
Journal:  Int J Cancer       Date:  1978-11-15       Impact factor: 7.396

9.  Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease.

Authors:  G Pallesen; S J Hamilton-Dutoit; M Rowe; L S Young
Journal:  Lancet       Date:  1991-02-09       Impact factor: 79.321

10.  Epstein-Barr virus (EBV) and Hodgkin's disease in a multi-ethnic population in Malaysia.

Authors:  S C Peh; L M Looi; G Pallesen
Journal:  Histopathology       Date:  1997-03       Impact factor: 5.087

View more
  19 in total

1.  Cervical cancer.

Authors:  P J van Diest; H Holzel
Journal:  J Clin Pathol       Date:  2002-04       Impact factor: 3.411

2.  The high frequency of EBV infection in pediatric Hodgkin lymphoma is related to the classical type in Bahia, Brazil.

Authors:  Iguaracyra Araujo; Achiléa Lisboa Bittencourt; Helenemarie S Barbosa; Eduardo Martins Netto; Núbia Mendonça; Hans-Dieter Foss; Michael Hummel; Harald Stein
Journal:  Virchows Arch       Date:  2006-08-01       Impact factor: 4.064

3.  Epstein-Barr virus and Hodgkin's lymphoma in Cairo, Egypt.

Authors:  Josée Audouin; Jacques Diebold; Bharat Nathwani; Elia Ishak; Kenneth Maclennan; Hans Konrad Mueller-Hermelink; James O Armitage; Dennis D Weisenburger
Journal:  J Hematop       Date:  2010-05-28       Impact factor: 0.196

4.  Macrophages predict treatment outcome in Hodgkin's lymphoma.

Authors:  Christian Steidl; Pedro Farinha; Randy D Gascoyne
Journal:  Haematologica       Date:  2011-02       Impact factor: 9.941

5.  Hodgkin lymphoma at the paediatric oncology unit of gabriel touré teaching hospital, bamako, mali: 5-year experience.

Authors:  B Togo; F Traoré; A P Togo; C B Traoré; K Dumke; M Diawara; A A Diakité; M Sylla; F Traoré-Dicko; B Traoré; T Sidibé
Journal:  Adv Hematol       Date:  2011-02-10

6.  Association of Hodgkin's lymphoma with Epstein Barr virus infection.

Authors:  Elmir Cickusić; Jasminka Mustedanagić-Mujanović; Ermina Iljazović; Zinaida Karasalihović; Ina Skaljić
Journal:  Bosn J Basic Med Sci       Date:  2007-02       Impact factor: 3.363

7.  Flow cytometry for assessment of the tumor microenvironment in pediatric Hodgkin lymphoma.

Authors:  Meret Henry; Steven Buck; Süreyya Savaşan
Journal:  Pediatr Blood Cancer       Date:  2018-07-15       Impact factor: 3.167

8.  Prognostic Biomarkers and EBV Infection Research in Diffuse Large B-Cell Lymphoma of the Palatine Tonsils.

Authors:  Marinho Marques; Estela Luz; Michael Hummel; Maria das Graças Vieira; Regina Célia Bahia; Maria Cristina Oliveira; Eduardo Martins Netto; Ivana Luz; Iguaracyra Araújo
Journal:  ISRN Oncol       Date:  2012-02-16

9.  EBV in pediatric neoplasia--intensity of infection as independent prognostic factor.

Authors:  S Căinap; A Răchişan; B Fetică; R Cosnarovici; E Mihuţ; G Popa; D Gheban; C Căinap
Journal:  J Med Life       Date:  2012-09-25

10.  Prognostic significance of EBV latent membrane protein 1 expression in lymphomas: evidence from 15 studies.

Authors:  Yuan Mao; Mei Ping Lu; Hong Lin; Da Wei Zhang; Ying Liu; Qing Dong Li; Zhi Gang Lv; Jia Ren Xu; Ren Jie Chen; Jin Zhu
Journal:  PLoS One       Date:  2013-04-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.